Health
PharmAust (ASX:PAA) advances testing against COVID-19 – The Market Herald
Clinical-stage oncology PharmAust (ASX:PAA) has advanced its monepantel drugs testing against COVID-19, in the race to find a vaccine for the virus
- Clinical-stage oncology PharmAust (PAA) has signed an agreement with Leiden University Medical (LUMC) for its monepantel drugs testing against COVID-19
- LUMC will test the effects of monepantel and monepantel sulfone on the replication of SARS-CoV-2 in cell lines
- Under the agreement, PharmAust will pay a fee to LUMC and will own all intellectual property results generated from the study
- The study will be overseen by Dr Martijn van Hemert, Principal Investigator of …
Continue Reading
-
General11 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News23 hours agoCat-Sitting Leads to Chaos for Austin Butler in the Trailer for Darren Aronofsky’s New Crime-Thriller ‘Caught Stealing’
-
Noosa News22 hours agoIs Auckland New Zealand’s New Cultural Capital?
-
General21 hours agoThree maps that show the scale of the NSW flood disaster